List of insiders holdings for CITIUS ONCOLOGY INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Citius Pharmaceuticals Inc. 10% Owner | 2024-08-16 16:34:29 | 66,049,615 0 | 66,049,615 | Form 13D |
| Mazur Leonard L Chief Executive Officer | 2024-08-30 16:05:15 | 3,700,000 0 | 3,700,000 | Form 4/A |
| Zhang Dahe Chief Financial Officer 10% Owner | 2022-10-13 17:19:55 | 0 1,725,000 | 1,725,000 | Form 3 |
| Yuan Xiaofeng 10XYZ Management LLC Chief Executive Officer 10% Owner | 2022-10-13 17:21:54 | 0 1,725,000 | 1,725,000 | Form 3 |
| HOLUBIAK MYRON Z Director | 2024-08-30 16:05:13 | 1,500,000 0 | 1,500,000 | Form 4/A |
| Bartushak Jaime Chief Financial Officer | 2024-08-30 16:05:10 | 1,400,000 0 | 1,400,000 | Form 4/A |
| Czuczman Myron Chief Medical Officer | 2024-08-30 16:05:12 | 1,400,000 0 | 1,400,000 | Form 4/A |
| Webb Carol Director | 2024-08-14 18:24:54 | 150,000 0 | 150,000 | Form 4 |
| MCGRATH DENNIS M Director | 2024-08-14 18:26:00 | 150,000 0 | 150,000 | Form 4 |
| Dutia Suren G Director | 2024-08-14 18:29:05 | 150,000 0 | 150,000 | Form 4 |
| Holuka Eugene Myron Director | 2024-08-16 16:06:41 | 150,000 0 | 150,000 | Form 4 |
| Hartzband Brian Shawn Director | 2022-10-13 17:19:37 | 0 0 | 0 | Form 3 |
| Mayersohn Joel David Director | 2022-10-13 17:23:24 | 0 0 | 0 | Form 3 |
| Jiang Cathy Director | 2022-10-13 17:23:49 | 0 0 | 0 | Form 3 |
| Smith Robert Joseph Director | 2024-08-14 18:23:50 | 0 0 | 0 | Form 3 |